The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until June, 2020.
A Preclinical Trial of Therapeutic Angiogenesis Plus Angioplasty and Stenting for Renal Vascular DiseaseSBC: Leflore Technologies LLC Topic: 400
Abstract Chronic kidney disease CKD is a progressive disorder affecting almost of the general population and this disease has shown a relentless growth over the past decades Patients with CKD have higher rates of hospitalization greater mortality shorter life expectancy and their healthcare costs are up to times more expensive than non CKD patients Thus treatments to slow halt ...STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
SBC: Mitotherapeutix LLC Topic: 300
Abstract The Specific Aim of this Phase I STTR proposal is to test the feasibility of treating non alcohol steatohepatitis NASH by increasing mitochondrial metabolism which is the main pathway for lipid catabolism in the liver NASH is a stage of non alcohol fatty liver disease NAFLD that has progressed to a pathological state NASH can lead to cirrhosis leading to liver failure or hepatocel ...STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
SBC: NALAS ENGINEERING SERVICES INC Topic: DTRA14B001
Nalas Engineering and Johns Hopkins University collaborated in a Phase I STTR program to study reactive mixtures of HI3O8 and nanocomposite fuels previously developed by the Weihs Group. These fuel/oxidizer mixtures are uniquely able to simultaneously produce heat and biocidal iodine gas, a combination designed to destroy biological weapons. The team at Nalas focused on evaluating conditions for p ...STTR Phase II 2017 Department of DefenseDefense Threat Reduction Agency